BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 34325118)

  • 1. Biomarker screening and validation for the differentiation of bloodstream infection from adult-onset Still's disease: A prospective cohort study.
    Zhang W; Yang T; Zhang H; Xu Y; Yang Q; Liu Q; Gao Y; Wu J; Shao L; Zhang W
    Cytokine; 2021 Oct; 146():155642. PubMed ID: 34325118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
    Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
    Front Immunol; 2018; 9():3099. PubMed ID: 30687316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of Interleukin-18 as a Diagnostic Biomarker to Differentiate Adult-Onset Still's Disease With/Without Macrophage Activation Syndrome From Other Secondary Hemophagocytic Lymphohistiocytosis in Adults.
    Shiga T; Nozaki Y; Tomita D; Kishimoto K; Hirooka Y; Kinoshita K; Funauchi M; Matsumura I
    Front Immunol; 2021; 12():750114. PubMed ID: 34691064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum Heparin-Binding Protein as a Potential Biomarker to Distinguish Adult-Onset Still's Disease From Sepsis.
    Tian R; Chen X; Yang C; Teng J; Qu H; Liu HL
    Front Immunol; 2021; 12():654811. PubMed ID: 33868298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 18: a biomarker for differential diagnosis between adult-onset Still's disease and sepsis.
    Priori R; Colafrancesco S; Alessandri C; Minniti A; Perricone C; Iaiani G; Palazzo D; Valesini G
    J Rheumatol; 2014 Jun; 41(6):1118-23. PubMed ID: 24786926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-37 is increased in adult-onset Still's disease and associated with disease activity.
    Chi H; Liu D; Sun Y; Hu Q; Liu H; Cheng X; Ye J; Shi H; Yin Y; Liu M; Wu X; Zhou Z; Teng J; Yang C; Su Y
    Arthritis Res Ther; 2018 Mar; 20(1):54. PubMed ID: 29566725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical manifestations but not cytokine profiles differentiate adult-onset Still's disease and sepsis.
    Rau M; Schiller M; Krienke S; Heyder P; Lorenz H; Blank N
    J Rheumatol; 2010 Nov; 37(11):2369-76. PubMed ID: 20810496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial use of serum ferritin and heme oxygenase-1 as biomarkers in adult-onset Still's disease: A multicenter retrospective study.
    Kirino Y; Kawaguchi Y; Tada Y; Tsukamoto H; Ota T; Iwamoto M; Takahashi H; Nagasawa K; Takei S; Horiuchi T; Ichida H; Minota S; Ueda A; Ohta A; Ishigatsubo Y
    Mod Rheumatol; 2018 Sep; 28(5):858-864. PubMed ID: 29278009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult-onset Still's disease: still a diagnosis of exclusion. A nested case-control study in patients with fever of unknown origin.
    Vanderschueren S; Hermans F; De Munter P; Knockaert D
    Clin Exp Rheumatol; 2012; 30(4):514-9. PubMed ID: 22510428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell distribution width is useful in discriminating adult onset Still's disease and sepsis within 24 hours after hospitalization.
    Park HJ; Song J; Park YB; Lee SK; Lee SW
    Korean J Intern Med; 2018 Nov; 33(6):1234-1240. PubMed ID: 28838228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum leucine-rich α2-glycoprotein is a useful biomarker for monitoring disease activity in patients with adult-onset Still's disease.
    Ha YJ; Kang EJ; Lee SW; Park YB; Lee SK; Song JS; Choi ST
    Scand J Rheumatol; 2015; 44(5):399-403. PubMed ID: 26079682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and hyperferritinemia diagnostic cutoff points for AOSD based on ROC curve: a Chinese experience.
    Lian F; Wang Y; Yang X; Xu H; Liang L
    Rheumatol Int; 2012 Jan; 32(1):189-92. PubMed ID: 20798946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome.
    Kasama T; Furuya H; Yanai R; Ohtsuka K; Takahashi R; Yajima N; Miwa Y; Kobayashi K
    Clin Rheumatol; 2012 May; 31(5):853-60. PubMed ID: 22322207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum VEGF-C as an evaluation marker of disease activity in adult-onset Still's disease.
    Chen X; Hu QY; Wang M; Jia J; Teng J; Sun Y; Cheng X; Ye J; Su Y; Shi H; Chi H; Zhou Z; Liu T; Wang Z; Wan L; Qiao X; Wang F; Wu X; Yang C; Liu HL
    Rheumatol Int; 2022 Jan; 42(1):149-157. PubMed ID: 34499196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-18 and fibroblast growth factor 2 in combination is a useful diagnostic biomarker to distinguish adult-onset Still's disease from sepsis.
    Koga T; Sumiyoshi R; Furukawa K; Sato S; Migita K; Shimizu T; Umeda M; Endo Y; Fukui S; Kawashiri SY; Iwamoto N; Ichinose K; Tamai M; Nakamura H; Origuchi T; Nonaka F; Yachie A; Kondo H; Maeda T; Kawakami A
    Arthritis Res Ther; 2020 May; 22(1):108. PubMed ID: 32381117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum S100A8/A9, but not follistatin-like protein 1 and interleukin 18, may be a useful biomarker of disease activity in adult-onset Still's disease.
    Kim HA; An JM; Nam JY; Jeon JY; Suh CH
    J Rheumatol; 2012 Jul; 39(7):1399-406. PubMed ID: 22660800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum sTREM-1 in adult-onset Still's disease: a novel biomarker of disease activity and a potential predictor of the chronic course.
    Wang Z; Chi H; Sun Y; Teng J; Feng T; Liu H; Cheng X; Ye J; Shi H; Hu Q; Jia J; Liu T; Wan L; Zhou Z; Qiao X; Yang C; Su Y
    Rheumatology (Oxford); 2020 Nov; 59(11):3293-3302. PubMed ID: 32276274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ferritin levels in adult Still's disease].
    Flatau E; Reichman N; Kaufman N
    Harefuah; 1999 Sep; 137(5-6):200-1, 263, 262. PubMed ID: 10959321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum cytokine profiles in patients with adult onset Still's disease.
    Choi JH; Suh CH; Lee YM; Suh YJ; Lee SK; Kim SS; Nahm DH; Park HS
    J Rheumatol; 2003 Nov; 30(11):2422-7. PubMed ID: 14677188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-18 as an efficient marker for remission and follow-up in patients with inactive adult-onset Still's disease.
    Jung KH; Kim JJ; Lee JS; Park W; Kim TH; Jun JB; Yoo DH
    Scand J Rheumatol; 2014; 43(2):162-9. PubMed ID: 24134323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.